| Sustained release of exendin-4 from tannic acid/Fe (III) nanoparticles prolongs blood glycemic control in a mouse model of type II diabetes Z He, Y Hu, Z Gui, Y Zhou, T Nie, J Zhu, Z Liu, K Chen, L Liu, KW Leong, ... Journal of controlled release 301, 119-128, 2019 | 71 | 2019 |
| A polyphenol-metal nanoparticle platform for tunable release of liraglutide to improve blood glycemic control and reduce cardiovascular complications in a mouse model of type … Z He, T Nie, Y Hu, Y Zhou, J Zhu, Z Liu, L Liu, KW Leong, Y Chen, ... Journal of controlled release 318, 86-97, 2020 | 38 | 2020 |
| Surface coating approach to overcome mucosal entrapment of DNA nanoparticles for oral gene delivery of glucagon-like peptide 1 T Nie, Z He, Y Zhou, J Zhu, K Chen, L Liu, KW Leong, HQ Mao, Y Chen ACS applied materials & interfaces 11 (33), 29593-29603, 2019 | 34 | 2019 |
| Sustained IGF-1 delivery ameliorates effects of chronic denervation and improves functional recovery after peripheral nerve injury and repair PJ Hanwright, C Qiu, J Rath, Y Zhou, N von Guionneau, KA Sarhane, ... Biomaterials 280, 121244, 2022 | 29 | 2022 |
| Elimination of intracellular calcium overload by BAPTA-AM-loaded liposomes: a promising therapeutic agent for acute liver failure Z Fu, Q Fan, Y Zhou, Y Zhao, Z He ACS applied materials & interfaces 11 (43), 39574-39585, 2019 | 20 | 2019 |
| Quaternary nanoparticles enable sustained release of bortezomib for hepatocellular carcinoma L Li, Y Zhang, Y Zhou, H Hu, Y Hu, C Georgiades, HQ Mao, FM Selaru Hepatology 76 (6), 1660-1672, 2022 | 15 | 2022 |
| Facile one-pot synthesis of 2-oxazoline J Zhu, M Zhou, W Jiang, Y Zhou, G Song, R Liu Tetrahedron Letters 91, 153637, 2022 | 6 | 2022 |
| A combination therapy of bortezomib, CXCR4 inhibitor, and checkpoint inhibitor is effective in cholangiocarcinoma in vivo L Li, Y Zhou, Y Zhang, H Hu, HQ Mao, FM Selaru Iscience 26 (3), 2023 | 3 | 2023 |
| Effect of Degree of Deacetylation of Chitosan/Chitin on Human Neural Stem Cell Culture FC Chang, Y Zhou, MM James, HM Zareie, Y Ando, J Yang, M Zhang Macromolecular Bioscience 23 (1), 2200389, 2023 | 2 | 2023 |
| Chitosan Scaffolds as Microcarriers for Dynamic Culture of Human Neural Stem Cells Y Ando, FC Chang, M James, Y Zhou, M Zhang Pharmaceutics 15 (7), 1957, 2023 | 1 | 2023 |
| 3D chitosan scaffolds support expansion of human neural stem cells in chemically defined condition FC Chang, MM James, AM Qassab, Y Zhou, Y Ando, M Shi, M Zhang Matter 6 (10), 3631-3660, 2023 | | 2023 |
| 3D Porous Scaffold-Based High-Throughput Platform for Cancer Drug Screening Y Zhou, G Pereira, Y Tang, M James, M Zhang Pharmaceutics 15 (6), 1691, 2023 | | 2023 |
| Enhanced Cell Penetration and Pluripotency Maintenance of hiPSCs in 3D Natural Chitosan Scaffolds Y Tang, Y Zhou, G Lin, M Zhang Macromolecular Bioscience 23 (6), 2200460, 2023 | | 2023 |
| Tu1558 A NOVEL COMBINATION TREATMENT INCLUDING BORTEZOMIB, CXCR4 INHIBITION AND CHECK POINT INHIBITION IS EFFECTIVE IN CHOLANGIOCARCINOMA IN VIVO L Li, Y Zhou, Y Zhang, H Hu, HQ Mao, FM Selaru Gastroenterology 164 (6), S-1414, 2023 | | 2023 |
| Bortezomib-loaded nanoparticles FM Selaru, H Mao, L Li, Y Zhou, Z He, K Chen US Patent App. 17/797,053, 2023 | | 2023 |
Hai-Quan MaoJohns Hopkins UniversityVerified email at jhu.edu
